Combined Oral Contraceptive Effects on Low-Grade Chronic Inflammatory Mediators in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
Polycystic ovary syndrome is associated with dyslipidemia, dysglycemia, metabolic syndrome, and low-grade chronic inflammation, which increase the risks for cardiovascular disease. Combined oral contraceptives may affect the mediators of low-grade chronic inflammation with potential additive risk in...
Saved in:
| Main Authors: | Sebastião Freitas de Medeiros, Matheus Antônio Souto de Medeiros, Nayara de Souza Santos, Bruna Barcelo Barbosa, Márcia Marly Winck Yamamoto |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | International Journal of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2018/9591509 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COMBINED ORAL CONTRACEPTIVES IN TREATMENT OF PATIENTS WITH POLYCYSTIC OVARY SYNDROME
by: M. A. Gevorkyan, et al.
Published: (2016-09-01) -
Hormonal contraception in women with polycystic ovary syndrome: Contraceptive and non-contraceptive effects. A clinical lecture
by: Olga A. Pustotina
Published: (2024-12-01) -
Combined Oral Contraceptives for Polycystic Ovary Syndrome: <i>Pro</i> and <i>Contra</i> (Review)
by: I. A. Mazerkina, et al.
Published: (2024-07-01) -
Comparison of resumption of ovulation after cessation of oral contraceptives and medroxyprogesterone acetate in women with polycystic ovary syndrome
by: Soo Jin Han, et al.
Published: (2024-12-01) -
Systematic low-grade chronic inflammation and intrinsic mechanisms in polycystic ovary syndrome
by: Hongxia Deng, et al.
Published: (2024-12-01)